Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It can cause fatigue, trouble with balance and coordination, muscle weakness, and vision problems. Having MS doesn’t ...

Add Yahoo as a preferred source to see more of our stories on Google. The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondary ...

Physical activity was associated with a lower risk of disability progression in multiple sclerosis (MS), longitudinal data showed. Compared with low physical activity, the risk of confirmed disability ...

Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis Tolebrutinib has the potential to be the ...

High fish consumption was linked with slower disability progression in MS. Benefits were seen for both lean and oily fish consumption. Protective effects were strongest with consistent fish ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed ...

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term ...

Share on Pinterest At a rehabilitation center in Germany, which specializes in neurological rehabilitation after a stroke or head injury, a patient uses the bionic Ekso exoskeleton. BSIP/Getty Images ...

The HERCULES study of tolebrutinib is the first and only to show reduced confirmed disability progression at 6 months in nonrelapsing secondary progressive multiple sclerosis (MS). The HERCULES ...

DEDHAM - A Dedham woman is trying to take the stigma out of disability aids. Noelle Connolly has been living with multiple sclerosis symptoms since she was 17 and was officially diagnosed at 23. "I ...